Table 3 HIV incidence by study period before and after propensity score matching.
Period | Status | SiVET | Non-SiVET | Incidence rate ratio (95% CI) | p-value | ||||
|---|---|---|---|---|---|---|---|---|---|
HIV + | PYAR | Incidence (95% CI) | HIV + | PYAR | Incidence (95% CI) | ||||
Concurrent | Before PSM | 17 | 484.9 | 3.5 (2.2–5.6) | 39 | 658.1 | 5.9 (4.3–8.1) | 0.59 (0.31–0.68) | 0.033 |
After PSM | 16 | 386.0 | 4.1 (2.5–6.8) | 20 | 428.1 | 4.7 (3.0–7.2) | 0.89 (0.43–1.80) | 0.364 | |
Pre-SiVET | Before PSM | 17 | 484.9 | 3.5 (2.2–5.6) | 105 | 2309.7 | 4.5 (3.8–5.5) | 0.77 (0.43–1.29) | 0.161 |
After PSM | 17 | 484.9 | 3.5 (2.2–5.6) | 18 | 436.1 | 4.1 (2.6–6.6) | 0.85 (0.41–1.75) | 0.316 | |
